- Home
- NERV vs MMA Comparison
NERV vs MMA Comparison
Compare NERV & MMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- MMA
- Stock Information
- Founded
- NERV 2007
- MMA 2013
- Country
- NERV United States
- MMA Australia
- Employees
- NERV N/A
- MMA N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- MMA
- Sector
- NERV Health Care
- MMA
- Exchange
- NERV Nasdaq
- MMA Nasdaq
- Market Cap
- NERV 12.6M
- MMA 13.4M
- IPO Year
- NERV 2014
- MMA 2024
- Fundamental
- Price
- NERV $1.77
- MMA $1.40
- Analyst Decision
- NERV Hold
- MMA
- Analyst Count
- NERV 1
- MMA 0
- Target Price
- NERV $5.00
- MMA N/A
- AVG Volume (30 Days)
- NERV 12.2K
- MMA 426.1K
- Earning Date
- NERV 08-05-2025
- MMA 01-21-2025
- Dividend Yield
- NERV N/A
- MMA N/A
- EPS Growth
- NERV N/A
- MMA N/A
- EPS
- NERV 0.83
- MMA N/A
- Revenue
- NERV N/A
- MMA $407,412.00
- Revenue This Year
- NERV N/A
- MMA N/A
- Revenue Next Year
- NERV N/A
- MMA N/A
- P/E Ratio
- NERV $2.18
- MMA N/A
- Revenue Growth
- NERV N/A
- MMA N/A
- 52 Week Low
- NERV $1.15
- MMA $0.60
- 52 Week High
- NERV $3.50
- MMA $4.11
- Technical
- Relative Strength Index (RSI)
- NERV 57.10
- MMA N/A
- Support Level
- NERV $1.62
- MMA N/A
- Resistance Level
- NERV $1.83
- MMA N/A
- Average True Range (ATR)
- NERV 0.09
- MMA 0.00
- MACD
- NERV -0.00
- MMA 0.00
- Stochastic Oscillator
- NERV 64.29
- MMA 0.00
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.